Year archive

MorphoSys AG — 2021 filings

All 121 regulatory filings released by MorphoSys AG (MOR) in 2021, sourced directly from the official regulator.

121 Filings

2021 Period

2021 filings (121)

Filing	Released	Lang
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-12-23	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-12-14	English
MorphoSys presents latest data from the Phase 2 MANIFEST Study evaluating the potential of pelabresib in the treatment of myelofibrosis Regulatory Filings	2021-12-12	English
MorphoSys and Incyte Announce Additional Real-World Evidence Results from RE-MIND2 Study of Tafasitamab (Monjuvi(R)) in Combination with Lenalidomide for the Treatment of r/r DLBCL Regulatory Filings	2021-12-11	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-12-08	English
DGAP-DD: MorphoSys AG english Director's Dealing	2021-12-06	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-12-06	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-12-01	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-12-01	English
Report Publication Announcement 2021 Report Publication Announcement	2021-11-30	English
Report Publication Announcement 2021 Report Publication Announcement	2021-11-30	English
MorphoSys AG: Corporate Calendar 2022 AGM Information	2021-11-29	English
DGAP-DD: MorphoSys AG english Director's Dealing	2021-11-25	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-11-25	English
DGAP-DD: MorphoSys AG english Director's Dealing	2021-11-23	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-11-12	English
Q3 statement / Q3 financial report 2021 Interim / Quarterly Report 9M 2021	2021-11-11	German
MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results Earnings Release 9M 2021	2021-11-10	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-11-10	English
MorphoSys Announces Departure of Roland Wandeler Board/Management Information	2021-11-09	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-11-09	English
MorphoSys presents interim results from M-PLACE study with felzartamab during American Society of Nephrology Annual Meeting Regulatory Filings	2021-11-04	English
MorphoSys to present MANIFEST and RE-MIND2 data from expanded hematology-oncology portfolio at the 2021 American Society of Hematology (ASH) Annual Meeting Report Publication Announcement	2021-11-04	English
MorphoSys AG announces Monjuvi(R) Sales for the First Nine Months and Third Quarter of 2021 and Invitation to the upcoming Conference Call on November 11, 2021 Earnings Release 9M 2021	2021-11-02	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-10-22	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-10-21	English
MorphoSys AG: First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Patients with Immunoglobulin A Nephropathy Legal Proceedings Report	2021-10-20	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-10-20	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-10-19	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-10-18	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-10-18	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-10-13	English
MorphoSys' Licensing Partner Roche Received Breakthrough Therapy Designation for Gantenerumab in Alzheimer's Disease Regulatory Filings	2021-10-11	English
DGAP-DD: MorphoSys AG english Director's Dealing	2021-10-04	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-10-04	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-10-01	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-09-29	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-09-27	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-09-24	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-09-23	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-09-23	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-09-23	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-09-23	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-09-23	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-09-23	English
Major Shareholding Notification 2021 Major Shareholding Notification	2021-09-20	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-09-20	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-09-20	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-08-31	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-08-27	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-08-27	English
MorphoSys and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory DLBCL Regulatory Filings	2021-08-26	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-08-25	English
Health Canada Grants Marketing Authorization for Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Regulatory Filings	2021-08-24	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-08-20	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-08-18	English
MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China M&A Activity	2021-08-17	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-08-12	English
DGAP-DD: MorphoSys AG english Director's Dealing	2021-08-03	English
DGAP-DD: MorphoSys AG english Director's Dealing	2021-08-03	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-08-02	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-08-02	English
Correction of a release from 30/07/2021, 14:30 CET/CEST - MorphoSys AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Declaration of Voting Results & Voting Rights Announcements	2021-08-02	English
DGAP-DD: MorphoSys AG english Director's Dealing	2021-07-30	English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Declaration of Voting Results & Voting Rights Announcements	2021-07-30	English
Half-yearly financial report 2021 Interim / Quarterly Report H2 2021	2021-07-29	German
MorphoSys AG Reports Second Quarter and First Half 2021 Results Earnings Release H1 2021	2021-07-28	English
Ad-hoc: MorphoSys AG to update financial guidance for 2021 and reduce financial liabilities Earnings Release H1 2021	2021-07-26	English
Invitation to MorphoSys' Second Quarter and First Half 2021 Results Conference Call on July 29, 2021 Report Publication Announcement	2021-07-21	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-07-21	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-07-21	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-07-21	English
MorphoSys Concludes a US$ 100 Million Capital Increase to Implement the Purchase of 1,337,552 shares by Royalty Pharma Share Issue/Capital Change	2021-07-16	English
MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology M&A Activity	2021-07-15	English
MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals M&A Activity	2021-07-01	English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Declaration of Voting Results & Voting Rights Announcements	2021-06-30	English
MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Regulatory Filings	2021-06-25	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-06-24	English
MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals M&A Activity	2021-06-16	English
DGAP-DD: MorphoSys AG english Director's Dealing	2021-06-07	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-06-07	English
MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL Regulatory Filings	2021-06-04	English
MorphoSys to Acquire Constellation Pharmaceuticals M&A Activity	2021-06-02	English
MorphoSys AG to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma M&A Activity	2021-06-02	English
MorphoSys To Participate in UBS Global Healthcare Conference Regulatory Filings	2021-05-21	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-05-20	English
MorphoSys to Present Data on Tafasitamab (Monjuvi(R)) at the 2021 ASCO Annual Meeting Regulatory Filings	2021-05-19	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-05-18	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-05-18	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-05-17	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-05-17	English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Declaration of Voting Results & Voting Rights Announcements	2021-05-14	English
MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-line Treatment for Diffuse Large B-Cell Lymphoma Legal Proceedings Report	2021-05-11	English
Q1 statement / Q1 financial report 2021 Interim / Quarterly Report Q1 2021	2021-05-10	German
MorphoSys AG Reports First Quarter 2021 Results Earnings Release Q1 2021	2021-05-05	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-05-04	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-04-29	English
Invitation to MorphoSys' First Quarter Results Conference Call on May 6, 2021 Report Publication Announcement	2021-04-28	English
Major Shareholding Notification 2021 Major Shareholding Notification	2021-04-26	English
Annual financial report 2020 Annual Report FY 2020	2021-04-21	English
MorphoSys and Incyte Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory FL or MZL Regulatory Filings	2021-04-19	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-04-19	English
DGAP-DD: MorphoSys AG english Director's Dealing	2021-04-14	English
MorphoSys AG: Bekanntmachung der Einberufung zur Hauptversammlung am 19.05.2021 in www.morphosys.de/hv mit dem Ziel der europaweiten Verbreitung gema 121 AktG AGM Information	2021-04-07	German
DGAP-DD: MorphoSys AG english Director's Dealing	2021-03-24	English
DGAP-DD: MorphoSys AG english Director's Dealing	2021-03-23	English
DGAP-DD: MorphoSys AG english Director's Dealing	2021-03-22	English
DGAP-DD: MorphoSys AG english Director's Dealing	2021-03-19	English
DGAP-DD: MorphoSys AG english Director's Dealing	2021-03-19	English
MorphoSys AG Presents Results for Full Year 2020 Earnings Release FY 2020	2021-03-15	English
Invitation to MorphoSys' Full Year Results 2020 Conference Call on March 16, 2021 Report Publication Announcement	2021-03-09	English
MorphoSys's Licensing Partner GSK Shared Preliminary Results From OSCAR Study with Otilimab for the Treatment of Severe Pulmonary COVID-19 Related Disease Regulatory Filings	2021-03-02	English
Ad hoc: MorphoSys AG preliminary results for the fiscal year 2020 exceeding guidance Earnings Release FY 2020	2021-03-01	English
Report Publication Announcement 2021 Report Publication Announcement	2021-02-26	English
Report Publication Announcement 2021 Report Publication Announcement	2021-02-26	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-02-25	English
MorphoSys AG: MorphoSys and I-Mab Announce First Patient Dosed in U.S. Phase 1 Study of MOR210/TJ210 in Patients with Advanced Cancer Legal Proceedings Report	2021-01-25	English
MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab Regulatory Filings	2021-01-12	English
MorphoSys To Present At the 39th Annual J.P. Morgan Healthcare Conference Regulatory Filings	2021-01-11	English
MorphoSys Appoints Sung Lee as Chief Financial Officer Board/Management Information	2021-01-06	English
MorphoSys and Incyte Announce the Acceptance of the Swissmedic Marketing Authorization Application for Tafasitamab Regulatory Filings	2021-01-05	English

Filings by year

2024 264 filings
2023 209 filings
2022 98 filings
2021 121 filings
2020 117 filings
2019 119 filings
2018 98 filings
2017 79 filings
2012 7 filings
2011 31 filings
2010 25 filings
2009 16 filings
2008 14 filings
2007 18 filings
2006 13 filings
2005 20 filings
2004 42 filings
2003 16 filings
2002 30 filings
2001 42 filings
2000 22 filings
1999 17 filings